Clinical Potentials of Cardiomyocytes Derived from Patient-Specific Induced Pluripotent Stem Cells

The lack of appropriate human cardiomyocyte-based experimental platform has largely hindered the study of cardiac diseases and the development of therapeutic strategies. To date, somatic cells isolated from human subjects can be reprogramed into induced pluripotent stem cells (iPSCs) and subsequentl...

Descripción completa

Detalles Bibliográficos
Autores principales: Ng, Kwong-Man, Law, Cheuk-Yiu, Tse, Hung-Fat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470173/
https://www.ncbi.nlm.nih.gov/pubmed/26237594
http://dx.doi.org/10.3390/jcm3041105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470173/
https://www.ncbi.nlm.nih.gov/pubmed/26237594
http://dx.doi.org/10.3390/jcm3041105

Ejemplares similares